SARA / Free Tools / CVE / CVE-2018-14786

CVE-2018-14786 — Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Ala

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality th

CVSS
— —
EPSS
7.32% (top 8.40%)
CWE
CWE-287
Published
2018-08-23T19:00:00.000Z
Last modified
2024-09-17T04:14:48.162Z
CVSS vector
—

01What is this vulnerability?

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various…

02Affected products

VendorProductVersions
Becton, Dickinson and CompanyAlaris GS, Alaris GH, Alaris CC, and Alaris TIVAVersion 2.3.6 and prior

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

09References

Want this in your SOAR or SIEM?
SARA's API returns EPSS, CVSS, KEV, and an analyst-grade summary in one call.
Read the API reference →